موارد یافت شده
سبد خرید
  1. انتشارات جعفری نوین
  2. لاتین
  3. Squamous cell Carcinoma: Molecular Therapeutic Targets کارسینوم سلول سنگفرشی
Squamous cell Carcinoma: Molecular Therapeutic Targets Springer
Squamous cell Carcinoma: Molecular Therapeutic Targets Springer Springer  

Squamous cell Carcinoma: Molecular Therapeutic Targets
کارسینوم سلول سنگفرشی

کد کتاب 186342

Squamous cell Carcinoma: Molecular Therapeutic Targets 1st ed

کتاب کارسینوم سلول سنگفرشی

افست = اورجینال
چاپ تمام رنگی
کاغذ 80 گرمی اندونزی
جلد سخت و ته دوخت

*بهترین کیفیت افست را از ما بخواهید*

این جلد ویرایش شده درباره درمان‌های هدفمند جدید برای درمان نئوپلاسم‌های پیشرفته سر و گردن (HNSCC) با اشاره خاص به کارسینوم سلول سنگفرشی دهان است و زمینه‌های خاصی از ژنتیک سرطان و ژنومیک برای پزشکی شخصی را پوشش می‌دهد.

ناشر : Springer ( نمایش همه کتاب های انتشارات Springer )
تعداد صفحه
281
چاپ
رنگی
زبان
انگلیسی
سال نشر
2018
شابک
9789402414851
قطع
رحلی
نوبت چاپ
یکم
نویسنده
Edited by Saman Warnakulasuriya - Edited by Zakir Khan

خرید Squamous cell Carcinoma: Molecular Therapeutic Targets

دارای 12% تخفیف  
مقدمه کتاب اطللاعات بیشتر پرسش و پاسخ

Squamous cell Carcinoma: Molecular Therapeutic Targets 1st ed

کتاب کارسینوم سلول سنگفرشی

This edited volume is about novel targeted therapies for the treatment of advanced neoplasms of the head and neck (HNSCC) with particular reference to oral squamous cell carcinomas and covers specific fields of cancer genetics and genomics for personalized medicine.



The landmark studies from the HNSCC Cancer Genome Anatomy (TCGA) and the cancer Genome Atlas 2015 have revealed the multiplicity and diversity of genetic alterations in HNSCC. This remarkable body of information has elucidated novel druggable targets (eg. EGFR, mTOR, p53, survivin and aberrant microRNA) for therapeutic interventions in head and neck cancer.



Readers will discover the importance of the biology and pathology of squamous cell carcinomas, the role of cancer stem cells and other factors that contribute to resistance to curative therapies such as hypoxia. We present an in-depth analysis of the HNSCC oncogenome describing the distinct molecular alterations in squamous cell carcinomas, which participate in specific molecular pathways whose dysregulation may contribute to most HNSCC cases. Final chapters of the book elucidate how these important cancer-driving molecular events and molecular pathways could be targeted to treat head and neck cancers and their therapeutic applications for targeted therapies based on clinical trials reported worldwide.



This book is aimed at a broad audience, including scientists, physicians, surgeons, and post graduate students engaged in oncology and provide the readers with an up-to-date, interdisciplinary knowledge and tools to better understand the evolving areas of targeted gene therapy and the key concept of personalized medicine in head and neck cancer.

Product details

  • Paperback | 281 pages
  • 155 x 235 x 15mm | 615g
  • Dordrecht, Netherlands
  • English
  • Softcover reprint of the original 1st ed. 2017
  • 15 Tables, color; 30 Illustrations, color; XII, 281 p. 30 illus. in color.
  • 9402414851
  • 9789402414851